Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

G-protein Coupled Receptors

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Human Genetics

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...

Pharmacogenetics of Drug Metabolism: Overview

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Assessing peripheral oxytocin and cortisol levels and epigenetic variations of oxytocin receptor and glucocorticoid receptor genes in school-aged preterm-born children.

Progress in neurobiology·2026

Same author

Stress-related fluctuations in personality functioning in daily life: Pilot data from an ambulatory monitoring study in outpatients diagnosed with borderline personality disorder.

Clinical psychology & psychotherapy·2026

Same author

Clinical and Cost-Effectiveness of Blended Cognitive Behavioral Therapy or Psychodynamic Therapy Versus Face-to-Face Psychotherapy for Depression (BLENDED Study): Protocol for a Pragmatic, Multicenter, Assessor-Blinded Randomized Controlled Noninferiority Trial.

JMIR research protocols·2026

Same author

NR3C1 Methylation and Perceived Parenting as Joint Predictors of the Development of Loneliness in Adolescence.

Journal of adolescence·2025

Same author

Predictors of treatment response trajectories to cognitive behavioral therapy for chronic fatigue syndrome: A cohort study.

Journal of psychosomatic research·2024

Same author

Investigating adverse daily life effects following a psychosocial laboratory stress task, and the moderating role of Psychopathology.

Stress (Amsterdam, Netherlands)·2024

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Glucocorticoid receptor polymorphisms in major depression.

Stephan Claes¹

¹University Psychiatric Centre, Catholic University Leuven, Leuven, Belgium. Stephan.Claes@uzleuven.be

Annals of the New York Academy of Sciences

|November 13, 2009

Summary

This summary is machine-generated.

Major depressive disorder (MDD) may involve stress system dysfunction. Research suggests the glucocorticoid receptor (GR) gene and its variations play a role in MDD vulnerability and neurobiology.

More Related Videos

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

Related Experiment Videos

Last Updated: Jun 18, 2026

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

Area of Science:

Neurobiology
Genetics
Endocrinology

Background:

Major depressive disorder (MDD) is linked to stress and hypothalamic-pituitary-adrenal (HPA) axis dysfunction.
Glucocorticoid receptor (GR) sensitivity is reduced in MDD, implicating GR in the disorder's neurobiology.
GR gene variations are investigated for their role in MDD.

Purpose of the Study:

To explore the role of the glucocorticoid receptor (GR) gene in the neurobiology of major depressive disorder (MDD).
To examine how single nucleotide polymorphisms (SNPs) in the GR gene affect GR function and HPA axis activity.
To assess the preliminary evidence for genetic variations in the GR gene contributing to MDD vulnerability.

Main Methods:

Review of in vitro and in vivo studies on GR sensitivity in MDD.
Analysis of transgenic animal models with impaired GR function.
Examination of genetic association studies on GR gene single nucleotide polymorphisms (SNPs).

Main Results:

Reduced GR sensitivity is observed in MDD patients.
Transgenic models with partial GR impairment exhibit MDD-consistent behaviors.
Preliminary evidence suggests GR gene variations influence MDD vulnerability.

Conclusions:

The glucocorticoid receptor (GR) and its gene are increasingly implicated in the neurobiology of major depressive disorder (MDD).
GR gene variations represent a significant area for research into the genetic underpinnings of MDD.
Further investigation into GR function and genetics is crucial for understanding MDD.